James Seibold
Rheumatology · Farmington, CTNPI 1821173337
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $269,105 of the $300,031 with a category attached, or 89.7%. Boehringer Ingelheim accounts for 87.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $242,559 and has fallen 97.6% since, to $5,901 in 2025. Among rheumatology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 112 payments — averaging $2678.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$261K
- AstraZeneca$10K
- Boehringer Ingelheim International GmbH$9K
- Boehringer Ingelheim Pharma GmbH & Co.kg$7K
- CSL Behring$5K
- Argenx US, Inc.$5K
- plus $2K from 1 others
Across 4 payments — averaging $2150.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Octapharma USA, Inc.$9K
What the payments were for
- Consulting fees$269,10590%
- Speaking & faculty fees$17,9246%
- Travel & lodging$10,5584%
- Food & beverage$2,4431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 85 | $261,263 |
| AstraZeneca | 4 | $10,004 |
| Boehringer Ingelheim International GmbH | 15 | $9,475 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 3 | $7,237 |
| CSL Behring | 3 | $5,301 |
| Argenx US, Inc. | 1 | $4,650 |
| GSK | 1 | $2,100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OFEV$257,103
- ULTOMIRIS$7,313
- NINTEDANIB$2,500
- Hizentra$1,575
How this compares
$300,031 in reported general payments places this provider in the 95th percentile of 118 rheumatology providers in Connecticut.
Other rheumatology in Farmington
- Rabeea NazirFarmington$3K
- Kenneth MillerDanbury$873K
- Robert SchoenGuilford$638K
- Bret SohnStamford$447K
- Fotios KoumpourasNorth Haven$314K
- Michael SpiegelDanbury$215K
- John MagaldiTorrington$157K
- Archana SharmaBristol$98K
- Richard RoseffDanbury$84K
- Beth ValashinasOrange$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.